BioSpectra, Inc. recalls Biospectra Tris/Tromethamine
- Published
- 14 Oct 2026
- Units affected
- 200 kg
- Agency
- FDA
- Country
- United States
The hazard
Failed stability specifications
Classification: Class II — this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.
What to do
Do not stop a prescribed medicine without talking to your doctor or pharmacist first. Ask them about a replacement, and return the recalled product to the pharmacy.
- Check the lot number on the box or bottle.
- Talk to your pharmacist or doctor before stopping any prescribed medicine.
- Return the product to the pharmacy for safe disposal.
Product details
Biospectra Tris/Tromethamine, USP, GMP, API Grade, Manufactured at 100 Majestic Way, Bangor, PA 18013, NDC 64173-101-25
- Brand / company
- BioSpectra, Inc.
- Codes / lots
- Lot#: TRIS -E04-0226-0016; Exp 2/29/28
- Distribution
- CA
- Recall status
- Ongoing
Source: U.S. Food and Drug Administration, published 14 Oct 2026. CheckMyRecalls reproduces the official notice in summary; always confirm the details with the original notice.